| Serial Number | 88393203 |
| Word Mark | VIROCURE |
| Filing Date | Friday, April 19, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 29, 2020 |
| Registration Number | 6231095 |
| Registration Date | Tuesday, December 29, 2020 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 13, 2020 |
| Indication of Colors claimed | The foreign registration includes a color claim or the legal equivalent for the colors blue, orange, and white. The colors blue, orange, and white are claimed as a feature of the mark in the U. S. application. |
| Description of Mark | The mark consists of the literal element "ViroCure" in stylized font with "VIRO" in orange and "CURE" in blue, to the right of a design element of a double helix in blue, outlined in white with an orange center with blue stripes all within a blue hexagon border. |
| Goods and Services | Custom manufacture of biopharmaceuticals; treatment of biopharmaceutical materials; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; processing of medical products; chemical treatment of liquids; preservation of pharmaceuticals; custom manufacture of medical devices for others; processing of blending agents for the manufacture of biopharmaceuticals; processing and handling of chemical reagents; processing of chemicals |
| Goods and Services | Medicine research; research for medical products; veterinary laboratory services; research and development of vaccines and medicines; pharmaceutical products development; research of pharmaceuticals; pharmaceutical research and development; pharmaceutical research services; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; clinical studies of medicines for research purposes; clinical testing of medicines for research purposes; pharmaceutical drug development services; testing/inspection or research of pharmaceuticals/cosmetics or foodstuff; development of biotechnology; research in the field of pharmacogenetics; biochemical research and development; scientific research for medical purposes in the field of cancerous diseases; conducting clinical trials for others for scientific research |
| Pseudo Mark | VIRO CURE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 6, 2019 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 6, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VIROCURE, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Guro-Gu Seoul 08381 KR |
| Party Name | VIROCURE, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Guro-Gu Seoul 08381 KR |
| Party Name | VIROCURE, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Guro-Gu Seoul 08381 KR |
| Event Date | Event Description |
| Tuesday, December 29, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 13, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 13, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 23, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 8, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 13, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 12, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 12, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 12, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 12, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 12, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 12, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 12, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 10, 2020 | ASSIGNED TO LIE |
| Wednesday, February 5, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, January 9, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, January 9, 2020 | LETTER OF SUSPENSION E-MAILED |
| Thursday, January 9, 2020 | SUSPENSION LETTER WRITTEN |
| Monday, January 6, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 6, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, July 7, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, July 7, 2019 | NON-FINAL ACTION E-MAILED |
| Sunday, July 7, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, June 28, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, May 7, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, May 6, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, April 23, 2019 | NEW APPLICATION ENTERED IN TRAM |